Repligen
RGEN
#2045
Rank
ยฃ6.96 B
Marketcap
ยฃ123.76
Share price
-0.47%
Change (1 day)
10.50%
Change (1 year)
Categories

Repligen (RGEN) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ1.56 Billion

According to Repligen 's latest financial reports the company has ยฃ1.56 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Repligen - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ1.57 B1.93%
2023-12-31$ยฃ1.54 B-2.35%
2022-12-31$ยฃ1.57 B21.82%
2021-12-31$ยฃ1.29 B15.57%
2020-12-31$ยฃ1.12 B38.81%
2019-12-31$ยฃ0.80 B66.65%
2018-12-31$ยฃ0.48 B10.8%
2017-12-31$ยฃ0.43 B220.02%
2016-12-31$ยฃ0.13 B65.12%
2015-12-31$ยฃ82.83 M15.42%
2014-12-31$ยฃ71.76 M13.95%
2013-12-31$ยฃ62.97 M21%
2012-12-31$ยฃ52.04 M
2011-03-31$ยฃ41.83 M-3.24%
2010-03-31$ยฃ43.23 M-9.54%
2009-03-31$ยฃ47.8 M49.78%
2008-03-31$ยฃ31.91 M145.26%
2007-03-31$ยฃ13.01 M-11.57%
2006-03-31$ยฃ14.71 M14.14%
2005-03-31$ยฃ12.89 M-11.89%
2004-03-31$ยฃ14.63 M-6.05%
2003-03-31$ยฃ15.57 M-16.07%
2002-03-31$ยฃ18.55 M-15%
2001-03-31$ยฃ21.83 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novavax
NVAX
-ยฃ0.12 Billion-107.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ4.54 B 190.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ2.25 B 44.19%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ14.26 B 813.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ38.37 B 2,355.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ13.95 B 792.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ69.83 B 4,369.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ1.47 B-5.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ4.68 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
ยฃ2.58 B 65.66%๐Ÿ‡บ๐Ÿ‡ธ USA